4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026448
Options or other derivatives
- Chief Medical Officer acquired 58,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2026-03-09 | Grant or award · Restricted Stock Units | +58,750 | 58,750 | D: show line 1 in the form |
Loading xslF345X05/tm268453-3_4seq1.xml…